Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Phase I Study of SB26 in Healthy Volunteers

This study is a Phase I, randomized double-blind, placebo-controlled (within a dose group), single and multiple rising dose study of the intravenous administration of SB26 in healthy volunteers.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - SB26

SB26 administered intravenously

Drug - Placebo

Placebo administered intravenously

Additional Information

Official Study Title

A Randomized, Double-blind, Placebo-controlled, Single and Multiple Rising Dose Study to Explore the Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of SB26 in Healthy Volunteers

Clinical Trial ID

NCT03630627

ParticipAid ID

eZ6Vwe